This is the delivery advantage that sets the HoMEso system apart
L-,
Antibodies against phosphorylated IR (p-IR)/IGF1R (catalog 3024), IR (catalog 3025), IGF1R (catalog 3027), -actin (catalog 4970), GAPDH (catalog 5174), p-AKT S473 (catalog 4060), AKT pan (catalog 4685), p-ERK1/2 T202/Y204 (catalog 4370), ERK1/2 (catalog 9102), p-Shc Y239/240 (catalog 2434), Shc (catalog 2432), p-Gab-1 Y627 (catalog 3233), Gab-1 (catalog 3232), p-mTOR S2481 (catalog 2974), mTOR (catalog 2972), p-c-Jun S73 (catalog 3270), c-Jun (catalog 9165), p- p-S6 S235/236 (catalog 2211), S6 (catalog 2217), p-JNK T183/Y185 (catalog 4668), and JNK (catalog 9252) were purchased from Cell Signaling Technology

[1] [4] If swelling occurs while taking a GLP-1 agonist, it is important to consider alternative explanations, including: Concurrent medications (e.g., calcium channel blockers, NSAIDs) Underlying cardiac, renal, or hepatic conditions Dietary changes or increased salt intake Venous insufficiency or lymphatic issues Patients experiencing unexplained swelling should not automatically attribute it to their GLP-1 medication without proper clinical assessment, as other potentially serious causes must be excluded